Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.58 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.43 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.42 |
| ▸ | GABRP | O00591 | 1/20 | 0.42 |
| ▸ | GABRD | O14764 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.42 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.42 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.42 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.42 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.42 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL631910 | 0.89 | TSHR (0.50) | TSHRSLC22A6LMNACYP1A2KMT2A | |
| Valeric Acid SCHEMBL12504185 | 0.86 | AKR1B1 (0.56) | TSHRSLC22A6LMNAHDAC3CYP1A2 | |
| Hexanoate SCHEMBL12504106 | 0.84 | AKR1B1 (0.67) | TSHRSLC22A6LMNACYP1A2BLM | |
| SCHEMBL5161389 | 0.83 | — | — | |
| SCHEMBL8852178 | 0.83 | TSHR (0.43) | TSHRLMNANFKB1PMP22CYP1A2 | |
| SCHEMBL1289888 | 0.78 | SLC22A6 (0.65) | TSHRSLC22A6LMNANFKB1PMP22 | |
| SCHEMBL312723 | 0.78 | SLC22A6 (0.65) | TSHRSLC22A6LMNANFKB1PMP22 | |
| SCHEMBL19925 | 0.78 | SLC22A6 (0.65) | TSHRSLC22A6LMNANFKB1PMP22 | |
| SCHEMBL1479653 | 0.76 | TSHR (0.44) | TSHRLMNABLMEGLN1ALDH1A1 | |
| Glutarate SCHEMBL6701735 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8247341-B2 | Procatalyst composition with silyl glutarate and method | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-08-21 | — | — | US | claimed |
| CN-102459358-A | Procatalyst composition with silyl glutarate and method therefor | DOW GLOBAL TECHNOLOGIES INC | 2012-05-16 | — | — | CN | claimed |
| EP-2419458-A1 | PROCATALYST COMPOSITION WITH SILYL GLUTARATE AND METHOD | Dow Global Technologies LLC (US) | 2012-02-22 | — | — | EP | claimed |
| US-20100267911-A1 | Procatalyst Composition with Silyl Glutarate and Method | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-10-21 | — | — | US | claimed |
| WO-2010120973-A1 | PROCATALYST COMPOSITION WITH SILYL GLUTARATE AND METHOD | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-10-21 | — | — | WO | claimed |
| EP-3592783-B1 | ELECTRON DONORS FOR ZIEGLER-NATTA PRECATALYST PREPARATION AND CATALYST SYSTEM FOR OLEFIN POLYMERIZATION | GRACE W R & CO (US) | 2025-11-12 | — | — | EP | disclosed |
| US-8247341-B2 | Procatalyst composition with silyl glutarate and method | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-08-21 | — | — | US | disclosed |
| US-8247341-B2 | Procatalyst composition with silyl glutarate and method | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-08-21 | — | — | US | disclosed |
| US-8247341-B2 | Procatalyst composition with silyl glutarate and method | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-08-21 | — | — | US | disclosed |
| CN-102459358-A | Procatalyst composition with silyl glutarate and method therefor | DOW GLOBAL TECHNOLOGIES INC | 2012-05-16 | — | — | CN | disclosed |
| CN-102459358-A | Procatalyst composition with silyl glutarate and method therefor | DOW GLOBAL TECHNOLOGIES INC | 2012-05-16 | — | — | CN | disclosed |
| CN-102459358-A | Procatalyst composition with silyl glutarate and method therefor | DOW GLOBAL TECHNOLOGIES INC | 2012-05-16 | — | — | CN | disclosed |
| EP-2419458-A1 | PROCATALYST COMPOSITION WITH SILYL GLUTARATE AND METHOD | Dow Global Technologies LLC (US) | 2012-02-22 | — | — | EP | disclosed |
| EP-2419458-A1 | PROCATALYST COMPOSITION WITH SILYL GLUTARATE AND METHOD | Dow Global Technologies LLC (US) | 2012-02-22 | — | — | EP | disclosed |
| US-20100267911-A1 | Procatalyst Composition with Silyl Glutarate and Method | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-10-21 | — | — | US | disclosed |
| US-20100267911-A1 | Procatalyst Composition with Silyl Glutarate and Method | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-10-21 | — | — | US | disclosed |
| US-20100267911-A1 | Procatalyst Composition with Silyl Glutarate and Method | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-10-21 | — | — | US | disclosed |
| WO-2010120973-A1 | PROCATALYST COMPOSITION WITH SILYL GLUTARATE AND METHOD | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-10-21 | — | — | WO | disclosed |
| WO-2010120973-A1 | PROCATALYST COMPOSITION WITH SILYL GLUTARATE AND METHOD | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-10-21 | — | — | WO | disclosed |
| WO-2010120973-A1 | PROCATALYST COMPOSITION WITH SILYL GLUTARATE AND METHOD | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267911-A1 | Procatalyst Composition with Silyl Glutarate and Method | MPST, TST, TKT | TSHR 3845/4885SLC22A6 793/4885LMNA 1306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.